Meningococcal B vaccine (4CMenB): the journey from research to real world experience
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meningococcal B vaccine (4CMenB): the journey from research to real world experience
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 17, Issue 12, Pages 1111-1121
Publisher
Informa UK Limited
Online
2018-11-21
DOI
10.1080/14760584.2018.1547637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
- (2018) M. Giuliani et al. Scientific Reports
- B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage ofNeisseria meningitidisin adolescents
- (2018) Helen S Marshall et al. BMJ Open
- Emerging experience with meningococcal serogroup B protein vaccines
- (2017) Daniela Toneatto et al. Expert Review of Vaccines
- Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016
- (2017) Lucy A McNamara et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
- (2017) Federico Martinón-Torres et al. VACCINE
- Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial
- (2017) Marco Aurelio P. Safadi et al. VACCINE
- Serogroup B Meningococcus Outbreaks, Prevalence, and the Case for Standard Vaccination
- (2017) James Grogan et al. Current Infectious Disease Reports
- Routinely vaccinating adolescents against meningococcus: targeting transmission & disease
- (2016) Volker Vetter et al. Expert Review of Vaccines
- The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
- (2016) Ray Borrow et al. Expert Review of Vaccines
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Meningococcal B Vaccine during a University Outbreak
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of a Meningococcal B Vaccine during a University Outbreak
- (2016) Nicole E. Basta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined
- (2016) Massimiliano Biagini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enter B and W: two new meningococcal vaccine programmes launched
- (2015) Shamez N Ladhani et al. ARCHIVES OF DISEASE IN CHILDHOOD
- A Large Portion of Meningococcal Antigen Typing System-Negative Meningococcal Strains from Spain Is Killed by Sera from Adolescents and Infants Immunized with 4CMenB
- (2015) R. Abad et al. Clinical and Vaccine Immunology
- The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme – New challenges for public health
- (2015) Shamez N. Ladhani et al. JOURNAL OF INFECTION
- First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University Outbreak
- (2015) L. A. McNamara et al. PEDIATRICS
- MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
- (2015) Duccio Medini et al. VACCINE
- Neisseria Adhesin A Variation and Revised Nomenclature Scheme
- (2014) Stefania Bambini et al. Clinical and Vaccine Immunology
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
- (2014) H. Christensen et al. BMJ-British Medical Journal
- A phase II randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)
- (2014) Susanna Esposito et al. Human Vaccines & Immunotherapeutics
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)
- (2014) Roman Prymula et al. Human Vaccines & Immunotherapeutics
- Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model
- (2014) Stéphane A Régnier et al. Human Vaccines & Immunotherapeutics
- Update on adolescent immunizations
- (2013) Tali Capua et al. CURRENT OPINION IN PEDIATRICS
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
- (2013) Timo Vesikari et al. LANCET
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease
- (2013) L. K. McNeil et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
- (2013) Giacomo Frosi et al. VACCINE
- Distinct Binding and Immunogenic Properties of the Gonococcal Homologue of Meningococcal Factor H Binding Protein
- (2013) Ilse Jongerius et al. PLoS Pathogens
- Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae
- (2012) Ronza Hadad et al. APMIS
- Transcriptional Regulation of thenadAGene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
- (2012) Luca Fagnocchi et al. INFECTION AND IMMUNITY
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules
- (2012) Nicoletta Gossger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
- (2012) Davide Serruto et al. VACCINE
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding
- (2011) Serena Giuntini et al. INFECTION AND IMMUNITY
- Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
- (2011) Richard Arnold et al. VACCINE
- Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States
- (2011) Xin Wang et al. VACCINE
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- (2011) David M. Vu et al. VACCINE
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
- (2010) Kate L. Seib et al. INFECTION AND IMMUNITY
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
- (2010) Davide Serruto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates
- (2009) Rolando Pajon et al. VACCINE
- The Promise and Challenge of Adolescent Immunization
- (2008) AMERICAN JOURNAL OF PREVENTIVE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now